[go: up one dir, main page]

AU2015903210A0 - Compositions and methods of treatment - Google Patents

Compositions and methods of treatment

Info

Publication number
AU2015903210A0
AU2015903210A0 AU2015903210A AU2015903210A AU2015903210A0 AU 2015903210 A0 AU2015903210 A0 AU 2015903210A0 AU 2015903210 A AU2015903210 A AU 2015903210A AU 2015903210 A AU2015903210 A AU 2015903210A AU 2015903210 A0 AU2015903210 A0 AU 2015903210A0
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015903210A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akaal Pharma Pty Ltd
Original Assignee
Akaal Pharma Pty Ltd
Filing date
Publication date
Application filed by Akaal Pharma Pty Ltd filed Critical Akaal Pharma Pty Ltd
Publication of AU2015903210A0 publication Critical patent/AU2015903210A0/en
Priority to PCT/AU2016/050732 priority Critical patent/WO2017024355A1/en
Priority to US15/751,709 priority patent/US20180228778A1/en
Priority to CA2993621A priority patent/CA2993621A1/en
Priority to AU2016305496A priority patent/AU2016305496A1/en
Priority to RU2018108109A priority patent/RU2018108109A/en
Priority to HK18113815.6A priority patent/HK1254769A1/en
Priority to JP2018526972A priority patent/JP2018527406A/en
Priority to KR1020187005158A priority patent/KR20180035840A/en
Priority to CN201680052675.8A priority patent/CN108024998A/en
Priority to MA042625A priority patent/MA42625A/en
Priority to EP16834321.8A priority patent/EP3334428A4/en
Abandoned legal-status Critical Current

Links

AU2015903210A 2015-08-11 2015-08-11 Compositions and methods of treatment Abandoned AU2015903210A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
EP16834321.8A EP3334428A4 (en) 2015-08-11 2016-08-11 COMPOSITIONS COMPRISING S1P RECEPTOR MODULATORS
RU2018108109A RU2018108109A (en) 2015-08-11 2016-08-11 COMPOSITIONS WITH S1P RECEPTOR MODULATORS
US15/751,709 US20180228778A1 (en) 2015-08-11 2016-08-11 Compositions comprising s1p receptor modulators
CA2993621A CA2993621A1 (en) 2015-08-11 2016-08-11 Compositions comprising s1p receptor modulators
AU2016305496A AU2016305496A1 (en) 2015-08-11 2016-08-11 Compositions comprising S1P receptor modulators
PCT/AU2016/050732 WO2017024355A1 (en) 2015-08-11 2016-08-11 Compositions comprising s1p receptor modulators
HK18113815.6A HK1254769A1 (en) 2015-08-11 2016-08-11 Compositions comprising s1p receptor modulators
JP2018526972A JP2018527406A (en) 2015-08-11 2016-08-11 Composition comprising an S1P receptor modulator
KR1020187005158A KR20180035840A (en) 2015-08-11 2016-08-11 Composition comprising an S1P receptor modulator
CN201680052675.8A CN108024998A (en) 2015-08-11 2016-08-11 Include the composition of S1P receptor modulators
MA042625A MA42625A (en) 2015-08-11 2016-08-11 COMPOSITIONS INCLUDING S1P RECEIVER MODULATORS

Publications (1)

Publication Number Publication Date
AU2015903210A0 true AU2015903210A0 (en) 2015-08-27

Family

ID=

Similar Documents

Publication Publication Date Title
EP3368559A4 (en) Compositions and methods for treatment of cancer
EP3288958A4 (en) Compositions of obeticholic acid and methods of use
EP3245291A4 (en) Novel micro-dystrophins and related methods of use
EP3377070A4 (en) Compounds and methods of their use
EP3256113A4 (en) Treatment of hypoparathyroidism
EP3268018A4 (en) Bacterial compositions and methods of use thereof
EP3408344A4 (en) Well treatment methods and compositions
EP3207048A4 (en) Compositions and methods of treating muscular dystrophy
EP3190886A4 (en) Compositions and methods of use thereof
EP3310783A4 (en) Methods and compositions for the prevention and treatment of hearing loss
EP3185872A4 (en) Formulations of testosterone and methods of treatment therewith
EP3253211A4 (en) Compositions and methods for treatment of edema
EP3154952A4 (en) Methods and compositions for treatment of her-positive cancers
EP3226873A4 (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
EP3185910A4 (en) Methods and compositions for the treatment of cancer
EP3134108A4 (en) Agents and methods of treatment
EP3368048A4 (en) Methods and compositions for the treatment of amyloidosis
EP3247364A4 (en) Compositions and methods of treating microbes
EP3258908A4 (en) Compositions and methods for treatment of skin infections
ZA201900984B (en) Methods and compositions for the treatment of warts
GB201511799D0 (en) Composition and methods of treatment
EP3151862A4 (en) Therapeutic detoxification compositions and methods of making and using same
EP3110435A4 (en) Methods and compositions for the delayed treatment of stroke
GB201621737D0 (en) Compositions and methods of treatment
EP3256094A4 (en) Dental compositions and methods of use